(Journal of Gastroenterology, 2018) evaluated BPC-157's efficacy in treating inflammatory bowel conditions
Quality and Safety Standards As a medical practice, patient safety and efficacy are our top priorities
The community protocol steps down by phase: 10 units on an insulin syringe (4 mg total blend: 2.5 mg GHK-Cu, 500 mcg KPV, 500 mcg BPC-157, 500 mcg TB-500) 5x/week during loading, then 5 units (2 mg total blend) 3x/week for maintenance
Really helped me
BPC 157 significantly corrected deranged muscle proliferation as well as myogenesis, counteracted an increase in proinflammatory and procachectic cytokines such as interleukin 6 (IL-6) and TNF- implicated in muscle metabolism relevant to cancer cachexia, as well as any changes in the expression of FoxO3a, p-AKT, p-mTOR, and P-GSK-3 [10]
Related compounds Explore related research peptides Ready to order 5-Amino-1MQ